Genetic heterogeneity of amyotrophic lateral sclerosis: implications for clinical practice and research.
about
Adducin at the Neuromuscular Junction in Amyotrophic Lateral Sclerosis: Hanging on for Dear LifeClinical and genetic basis of familial amyotrophic lateral sclerosisiPSC-Based Models to Unravel Key Pathogenetic Processes Underlying Motor Neuron Disease DevelopmentProspects for bone marrow cell therapy in amyotrophic lateral sclerosis: how far are we from a clinical treatment?Calcium dysregulation links ALS defective proteins and motor neuron selective vulnerabilityA novel amyotrophic lateral sclerosis mutation in OPTN induces ER stress and Golgi fragmentation in vitro.Amyotrophic lateral sclerosis: a focus on disease progressionPrognostic factors for the course of functional status of patients with ALS: a systematic review.Quantifying disease progression in amyotrophic lateral sclerosis.An indicator cell assay for blood-based diagnostics.Importance of sample size for the estimation of repeater F waves in amyotrophic lateral sclerosisRare Variants in Neurodegeneration Associated Genes Revealed by Targeted Panel Sequencing in a German ALS Cohort.Prognostic and predictive role of vascular endothelial growth factor polymorphisms in breast cancer.Challenges in the Understanding and Treatment of Amyotrophic Lateral Sclerosis/Motor Neuron Disease.Neuroimaging as a New Diagnostic Modality in Amyotrophic Lateral Sclerosis.Pathogenesis of amyotrophic lateral sclerosis.Ethical issues in the evaluation of adults with suspected genetic neuromuscular disorders.Genotype-phenotype relationships in familial amyotrophic lateral sclerosis with FUS/TLS mutations in Japan.Translation of the focus toward excellence in translational science: comment on "TDP-43 Repression of Nonconserved Cryptic Exons is Compromised in ALS-FTD".Shortcomings in the Current Amyotrophic Lateral Sclerosis Trials and Potential Solutions for Improvement.The Anatomy to Genomics (ATG) Start Genetics medical school initiative: incorporating exome sequencing data from cadavers used for Anatomy instruction into the first year curriculum.Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials.Critical Role of Trp-588 of Presynaptic Munc13-1 for Ligand Binding and Membrane Translocation.A unique account of ALS in China: exploring ethnic heterogeneity.Resveratrol inhibits phorbol ester-induced membrane translocation of presynaptic Munc13-1.Revealing the microstructural brain damage in amyotrophic lateral sclerosis: the relentless pursuit to approach an imaging biomarker.Differential Expression of Several miRNAs and the Host Genes AATK and DNM2 in Leukocytes of Sporadic ALS Patients.Correlating serum micrornas and clinical parameters in amyotrophic lateral sclerosis.Familial Amyotrophic Lateral Sclerosis.
P2860
Q26767792-6D44B450-FF60-4915-B040-7F99F5CF908CQ26783236-F4966D37-8C31-4C56-9058-41170781A620Q26863612-A1654F17-0732-476A-BC3A-EF4ECFB1B664Q28080065-F3302888-EACF-4879-95C1-BA85BA310AE7Q28084373-387E4DD4-B464-4190-A21A-A5280D2A858DQ29347553-B048C93C-F6F0-4906-BFBC-45A327C78C4FQ34064143-3A19BF97-BF6D-42BB-94CD-B205FE41BDE9Q34447158-ACA58A92-EFD0-47AF-9E30-6CD3A7D6EC5EQ35008605-00617D2A-A790-4789-8D91-066F6536B254Q36395874-7A9C1219-1612-45AC-96A1-F4B974BBC805Q36811686-DAB23363-AA09-4C2D-AD91-099BEC1C0125Q37334870-50D68E9C-F21E-44EA-B540-2D48E30EAC88Q38308001-4B266F63-E73A-4EC4-9ABC-54D815BB2DE4Q38312121-334FABA3-0FF4-4C2D-969C-6E084B21DF14Q38384260-2D95C1B4-2CAB-4EAC-87CC-80C8AB8CA5A5Q38906347-F8E1197E-2363-4747-AF01-2D851E8BD319Q38951129-FC9749B0-A044-44D9-BEF1-0284C9DE33DAQ40045594-DFB13EFB-7BEB-4325-B310-D21A158DDCE1Q42222944-46548265-F5DC-41BF-AAE3-E58A3A8A5906Q42369773-BDCE055A-70A1-4CA6-9FBC-8404C0AF53EDQ42386743-3EB94512-814D-4C1B-B8BD-ABD42672615EQ45671159-E1FB3AA0-AA7F-4EFE-81E4-5A2C04CB26C9Q47290370-161D248E-95C2-4C00-9C1A-61E79FBC4A09Q48099072-38FFFF0F-9077-4739-B539-F14CE064525EQ50888051-DB2B58AB-1ABD-439D-990D-979086801832Q52092218-04D9AA72-1903-4D89-B796-D97CCC143098Q52579274-19D785CA-E807-4667-A498-6536AF86A788Q53512219-08082762-7723-43C3-ABC2-113179A69405Q54158931-6DD3160D-B552-476D-9777-CCA4057CE67F
P2860
Genetic heterogeneity of amyotrophic lateral sclerosis: implications for clinical practice and research.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Genetic heterogeneity of amyot ...... linical practice and research.
@ast
Genetic heterogeneity of amyot ...... linical practice and research.
@en
Genetic heterogeneity of amyot ...... linical practice and research.
@nl
type
label
Genetic heterogeneity of amyot ...... linical practice and research.
@ast
Genetic heterogeneity of amyot ...... linical practice and research.
@en
Genetic heterogeneity of amyot ...... linical practice and research.
@nl
prefLabel
Genetic heterogeneity of amyot ...... linical practice and research.
@ast
Genetic heterogeneity of amyot ...... linical practice and research.
@en
Genetic heterogeneity of amyot ...... linical practice and research.
@nl
P2093
P2860
P356
P1433
P1476
Genetic heterogeneity of amyot ...... linical practice and research.
@en
P2093
Glenn S Gerhard
James R Connor
Zachary Simmons
P2860
P304
P356
10.1002/MUS.24198
P577
2014-04-08T00:00:00Z